Disc Medicine, Inc.
bitopertin
Erythropoietic Porphyrias (EPP & XLP)
Date
TBD
Advisory committee · Date TBD estimated
What's at stake
An FDA advisory committee reviews bitopertin for Erythropoietic Porphyrias (EPP & XLP) around Date TBD. The panel's public vote often front-runs the agency's final verdict — and the share price.
Primary source
· SEC 8-K
verified 14h ago
“Type C Meeting EOP2 Meeting September 2024”